Skip to main content
. Author manuscript; available in PMC: 2022 Apr 18.
Published in final edited form as: Sci Transl Med. 2022 Jan 26;14(629):eabl3836. doi: 10.1126/scitranslmed.abl3836

Table 1.

Participant baseline characteristics.

Characteristic Number or median Percent or IQR
Cohort, n (% of cohort)
100 to 199 CD4+/µl 9 28%
200 to 350 CD4+/µl 12 38%
>350 CD4+/µl 11 34%
Age, median (IQR) 55 (48, 61)
Sex, n (% of cohort)
Men 29 91%
Women 3 9%
Race, n (% of cohort)
White 19 59%
Black/African-American 9 28%
Other/unknown/more than 1 4 13%
Ethnicity
Hispanic 3 9%
Non-Hispanic 28 88%
Not reported 1 3%
Cancer, n (% of cohort)
AIDS-defining 10 31%
Non–AIDS-defining 22 69%
CD4:CD8 ratio, n (% of cohort)
<0.5 16 50%
≥0.5 16 50%
Plasma HIV RNA, n (% of cohort)
Below limit of detection 29 91%
Detected 3 9%